General Information of Drug Off-Target (DOT) (ID: OTBTPR2T)

DOT Name Peptidoglycan recognition protein 1 (PGLYRP1)
Synonyms Peptidoglycan recognition protein short; PGRP-S
Gene Name PGLYRP1
Related Disease
Bacterial infection ( )
Chronic kidney disease ( )
Crohn disease ( )
Gram-positive bacterial infection ( )
Immunodeficiency ( )
Inflammatory bowel disease ( )
Melanoma ( )
Neoplasm ( )
Nephropathy ( )
Psoriasis ( )
Ulcerative colitis ( )
Rheumatoid arthritis ( )
Parkinson disease ( )
UniProt ID
PGRP1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1YCK
Pfam ID
PF01510
Sequence
MSRRSMLLAWALPSLLRLGAAQETEDPACCSPIVPRNEWKALASECAQHLSLPLRYVVVS
HTAGSSCNTPASCQQQARNVQHYHMKTLGWCDVGYNFLIGEDGLVYEGRGWNFTGAHSGH
LWNPMSIGISFMGNYMDRVPTPQAIRAAQGLLACGVAQGALRSNYVLKGHRDVQRTLSPG
NQLYHLIQNWPHYRSP
Function
Innate immunity protein that plays several important functions in antimicrobial and antitumor defense systems. Acts as a pattern receptor that binds to murein peptidoglycans (PGN) of Gram-positive bacteria and thus provides bactericidal activity. Forms an equimolar complex with heat shock protein HSPA1A and induces programmed cell death through apoptosis and necroptosis in tumor cell lines by activating the TNFR1 receptor on the target cell membrane. In addition, acts in complex with the Ca(2+)-binding protein S100A4 as a chemoattractant able to induce lymphocyte movement. Mechanistically, this complex acts as a ligand of the chemotactic receptors CCR5 and CXCR3 which are present on the cells of the immune system. Promotes also the activation of lymphocytes that become able to kill virus-infected cells as well as tumor cells by modulating the spectrum of their target-cell specificity. Induction of cytotoxicity on monocyte surface requires interaction with TREM1 receptor.
Tissue Specificity Highly expressed in bone marrow. Weak expression found in kidney, liver, small intestine, spleen, thymus, peripheral leukocyte, lung, fetal spleen and neutrophils.
Reactome Pathway
Antimicrobial peptides (R-HSA-6803157 )
Neutrophil degranulation (R-HSA-6798695 )

Molecular Interaction Atlas (MIA) of This DOT

13 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Bacterial infection DIS5QJ9S Strong Altered Expression [1]
Chronic kidney disease DISW82R7 Strong Biomarker [2]
Crohn disease DIS2C5Q8 Strong Genetic Variation [3]
Gram-positive bacterial infection DISZ44JH Strong Biomarker [4]
Immunodeficiency DIS093I0 Strong Biomarker [5]
Inflammatory bowel disease DISGN23E Strong Genetic Variation [3]
Melanoma DIS1RRCY Strong Biomarker [6]
Neoplasm DISZKGEW Strong Biomarker [7]
Nephropathy DISXWP4P Strong Biomarker [2]
Psoriasis DIS59VMN Strong Genetic Variation [8]
Ulcerative colitis DIS8K27O Strong Genetic Variation [3]
Rheumatoid arthritis DISTSB4J moderate Biomarker [9]
Parkinson disease DISQVHKL Limited Genetic Variation [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Peptidoglycan recognition protein 1 (PGLYRP1). [11]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Peptidoglycan recognition protein 1 (PGLYRP1). [14]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Peptidoglycan recognition protein 1 (PGLYRP1). [12]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Peptidoglycan recognition protein 1 (PGLYRP1). [13]
------------------------------------------------------------------------------------

References

1 Dehydration triggers ecdysone-mediated recognition-protein priming and elevated anti-bacterial immune responses in Drosophila Malpighian tubule renal cells.BMC Biol. 2018 May 31;16(1):60. doi: 10.1186/s12915-018-0532-5.
2 Association of the salivary triggering receptor expressed on myeloid cells/its ligand peptidoglycan recognition protein 1 axis with oral inflammation in kidney disease.J Periodontol. 2018 Jan;89(1):117-129. doi: 10.1902/jop.2017.170218.
3 Genetic Association of Peptidoglycan Recognition Protein Variants with Inflammatory Bowel Disease.PLoS One. 2013 Jun 19;8(6):e67393. doi: 10.1371/journal.pone.0067393. Print 2013.
4 Molecular characteristics of hemoglobins in blood clam and their immune responses to bacterial infection.Int J Biol Macromol. 2017 Jun;99:375-383. doi: 10.1016/j.ijbiomac.2017.02.078. Epub 2017 Feb 24.
5 The peptidoglycan recognition protein PGRP-LE regulates the Drosophila immune response against the pathogen Photorhabdus.Microb Pathog. 2019 Nov;136:103664. doi: 10.1016/j.micpath.2019.103664. Epub 2019 Aug 9.
6 Phase I/II trial of gene therapy with autologous tumor cells modified with tag7/PGRP-S gene in patients with disseminated solid tumors: miscellaneous tumors.Ann Oncol. 2005 Jan;16(1):162-8. doi: 10.1093/annonc/mdi028.
7 FasL and the NKG2D receptor are required for the secretion of the Tag7/PGRP-S-Hsp70 complex by the cytotoxic CD8(+) lymphocytes.IUBMB Life. 2017 Jan;69(1):30-36. doi: 10.1002/iub.1587. Epub 2016 Nov 20.
8 Association of psoriasis to PGLYRP and SPRR genes at PSORS4 locus on 1q shows heterogeneity between Finnish, Swedish and Irish families.Exp Dermatol. 2009 Feb;18(2):109-15. doi: 10.1111/j.1600-0625.2008.00769.x. Epub 2008 Jul 17.
9 Serum PGLYRP? is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis.Mol Med Rep. 2019 Jan;19(1):589-594. doi: 10.3892/mmr.2018.9632. Epub 2018 Nov 8.
10 Peptidoglycan recognition protein genes and risk of Parkinson's disease.Mov Disord. 2014 Aug;29(9):1171-80. doi: 10.1002/mds.25895. Epub 2014 May 17.
11 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
12 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
13 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
14 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.